MedTrace Logo

COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave

NCT04782427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1197

Last updated 2021-07-28

No results posted yet for this study

Summary

The medical charts of all COVID-19 cases (n=1200) from 17 long-term care facilities in Montreal, Canada will be reviewed, to compare patients who survived to patients who did not survive. Through multilevel logistic regression, the risk of death will be estimated for institutional predictors of mortality, while controlling for individual risk factors.

Individual covariates include clinical features (age, sex, Charlston comorbidity index, SMAF autonomy score, severity criteria) and medical treatments (IV fluids, anticoagulation, oxygen, regular opiates, corticosteroids). Aggregate covariates include epidemiological data (attack rates, timing of outbreak) and institutional characteristics (number of beds, air exchange per hour, presence of a dedicated COVID-19 unit at the time of outbreak, staff compliance to infection control measures, staff infection rates, understaffing, proportion of semi-private rooms, proportion of wandering wards and other special units).

Conditions

  • Covid19
  • Death
  • Infection Viral
  • Infections, Respiratory
  • Infection, Coronavirus
  • Elderly Infection
  • Old Age; Dementia
  • Epidemic Disease

Interventions

OTHER

COVID-19 infection

Case of nosocomial infection within the long-term care facility

Sponsors & Collaborators

  • Université de Montréal

    collaborator OTHER

  • Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

    lead OTHER_GOV

Principal Investigators

  • Sophie Zhang, M.D. · Université de Montréal

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-04-13
Completion
2021-05-13

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782427 on ClinicalTrials.gov